Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000056

President & COO sold 847 shares at $16.00 ($13,552)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dowden Nathan J President & COO 2024-09-26 Sale 10b5-1 −847 $16.00 $13,552 125,149 D: show line 1 in the form
Open-market sales · 847 sh · avg $16.00 · $13,552
Loading xslF345X05/wk-form4_1727728325.xml…